Return to homepagePandemic Pact

Safety of breastfeeding (BF) in confirmed SARS-COV-2 (COVID-19) infection

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_01046

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Adelina Pellicer Martinez

  • Research Location

    Spain

  • Lead Research Institution

    FUNDACION PARA LA INVESTIGACIÇÿN BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PAZ

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Infants (1 month to 1 year)Newborns (birth to 1 month)

  • Vulnerable Population

    Pregnant womenOther

  • Occupations of Interest

    Unspecified

Abstract

Currently there are no formal studies on the efficacy of BF in the transfer of protective factors against SARS_COV-2, and its safety, understood as the exclusion of it as a source of spread of the virus and cause of illness in infants. BF is essential for the correct development of the most vulnerable neonatal populations. This cohort study will evaluate whether there is transmission of the virus through BF (using highly sensitive technology) and whether it depends on viral load. In addition, it will investigate the transfer of immunological / inflammatory factors and microbiological markers potentially associated with the severity of Covid-19